Catechol derivatives inhibit the fibril formation of amyloid-β peptides

Journal of Bioscience and Bioengineering

Volumn 109, Issue 6, 2010, Pages 629-634

  Huong, Vu Thi ^a   Shimanouchi, Toshinori ^a   Shimauchi, Naoya ^a   Yagi, Hisashi ^b   Umakoshi, Hiroshi ^a   Goto, Yuji ^b   Kuboi, Ryoichi ^a  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; Amyloid beta; Catechol derivatives; Fibril formation; Inhibitor; Liposome

Indexed keywords

ALZHEIMER'S DISEASE; BIOMEMBRANES; CATECHOL DERIVATIVES; CHEMICAL STRUCTURE; DOSE-DEPENDENT; FIBRIL FORMATION; INHIBITION EFFECT; INHIBITORY ACTIVITY; INHIBITORY EFFECT; SCHIFF-BASE; TEM; THERAPEUTIC TARGETS; THIOFLAVIN T; TOTAL INTERNAL REFLECTION FLUORESCENCE MICROSCOPY;

FLUORESCENCE; FLUORESCENCE MICROSCOPY; FUZZY CONTROL; GLYCOPROTEINS; PROTEINS; REFRACTIVE INDEX; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY;

PHENOLS;

AMYLOID BETA PROTEIN; CATECHOL DERIVATIVE; LIPOSOME;

ARTICLE; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; CIRCULAR DICHROISM; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; MEMBRANE; MOLECULAR DYNAMICS; PROTEIN ANALYSIS; PROTEIN SECONDARY STRUCTURE; TRANSMISSION ELECTRON MICROSCOPY;

AMYLOID; AMYLOID BETA-PROTEIN; CATECHOLS; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, FLUORESCENCE; PEPTIDE FRAGMENTS; THIAZOLES;

EID: 77952107424     PISSN: 13891723     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbiosc.2009.11.010     Document Type: Article

References (33)

1. Mattson M.P. Pathways towards and away from Alzheimer's disease. Nature 430 (2004) 631-639
2. Iversen L.L., Mortishiresmith R.J., Pollack S.J., and Shearman M.S. The toxicity in vitro of β-amyloid protein. Biochem. J. 311 (1995) 1-16
3. Yankner B.A. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 16 (1996) 921-932
4. Resende R., Ferreiro E., Pereira C., and Resende D.O.C. Neurotoxic effect of oligomeric and fibrillar species of amyloid-beta peptide 1-42: involvement of endoplasmic reticulum calcium release in oligomer-induced cell death. Neuroscience 155 (2008) 725-737
5. Kayed R., Head E., Thompson J.L., McIntire T.M., Milton S.C., Cotman C.W., and Glabe C.G. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300 (2003) 486-489
6. Kobayashi M., Kim J., Kobayashi N., Han S., Nakamura C., Ikebukuro K., and Sode K. Pyrroloquinoline quinone (PQQ) prevents fibril formation of α-synuclein. Biochem. Biophys. Res. Com. 349 (2006) 1139-1144
7. Felice F.G.D., Houzel J.C., Garcia-Abreu J., Louzada Jr. P.R.F., Afonso R.C., Meirelles M.N.L., Lent R., Neto V.M., and Ferreira S.T. Inhibition of Alzheimer's disease β-amyloid aggregation, neurotoxicity, and in vivo deposition by nitrophenols: implications for Alzheimer's therapy. FASEB J. 15 (2001) 1297-1299
8. Durairajan S.S.K., Yuan Q., Xie L., Chan W.S., Kum W.F., Koo I., Liu C., Song Y., Huang J.D., Klein W.L., and Li M. Salvianolic acid B inhibits Aβ fibril formation and disaggregates preformed fibrils and protects against Aβ-induced cytotoxicty. Neurochem. Int. 52 (2008) 741-750
9. Ikeda K., Okada T., Sawada S., Akiyoshi K., and Matsuzaki K. Inhibition of the formation of amyloid β-protein fibrils using biocompatible nanogels as artificial chaperones. FEBS Lett. 580 (2006) 6587-6595
10. Howlett D.R., Perry A.E., Godfey F., Swatton J.E., Jennings K.H., Spitzfaden C., Wadsworth H., Wood S.J., and Markwell R.E. Inhibition of fibril formation in β-amyloid peptide by a novel series of benzofurans. Biochem. J. 340 (1999) 283-289
11. Zhu M., Rajamani S., Kaylor J., Han S., Zhou F., and Fink A.L. The flavonoid baicalein inhibits fibrillation of α-synuclein and disaggregates existing fibrils. J. Biol. Chem. 279 (2004) 26846-26857
12. Ono K., Hasegawa K., Naiki H., and Yamada M. Curcumin has potent anti-amyloidogenic effects for Alzheimer's β-amyloid fibrils in vitro. J. Neurosci. Res. 75 (2004) 742-750
13. Ono K., Hasegawa K., Naiki H., and Yamada M. Anti-Parkinsonian agents have anti-amyloidogenic activity for Alzheimer's β-amyloid fi{ligature}brils in vitro. Neurochem. Int. 48 (2006) 275-285
14. Smith M.A., Rottkamp C.A., Nunomura A., Raina A.K., and Perry G. Oxidative stress in Alzheimer's disease. Biochim. Biophys. Acta 1502 (2000) 139-144
15. Behl C., Davis J., Cole G.M., and Schubert D. Vitamin E protects nerve cells from amyloid beta protein toxicity. Biochem. Biophys. Res. Commun. 186 (1992) 944-950
16. Morris M.C., Evans D.A., Bienias J.L., Tangney C.C., and Wilson R.S. Vitamin E and cognitive decline in older persons. Arch. Neurol. 59 (2002) 1125-1132
17. Kihara T., Shimohama S., Sawada H., Kimura J., Kume T., Kochiyama H., Maeda T., and Akaike A. Nicotinic receptor stimulation protects neurons against beta-amyloid toxicity. Ann. Neurol. 42 (1997) 159-163
18. Ono K., Hirohata M., and Yamada M. Anti-fibrillogenic and fibril-destabilizing activity of nicotine in vitro: implications for the prevention and therapeutics of Lewy body diseases. Exp. Neurol. 205 (2007) 414-424
19. Okuda T., Kimura Y., Yoshida T., Hatano T., Okuda H., and Arichi S. Studies on the activities of tannins and related compounds from medicinal plants and drugs: I. Inhibitory effects on lipid peroxidation in mitochondria and microsomes of liver. Chem. Pharm. Bull. (Tokyo) 31 (1983) 1625-1631
20. Ono K., Yoshiike Y., Takashima A., Hasegawa K., Naiki H., and Yamada M. Potent anti-amyloidogenic and fi{ligature}bril-destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease. J. Neurochem. 87 (2003) 172-181
21. Ono K., Hasegawa K., Naiki H., and Yamada M. Anti-amyloidogenic activity of tannic acid and its activity to destabilize Alzheimer's β-amyloid fibrils in vitro. Biochim. Biophys. Acta 1690 (2004) 193-202
22. Conway K.A., Rochet J.C., Bieganski R.M., and Lansbury P.T. Kinetic stabilization of the α-synuclein protofibril by a dopamine-α-synuclein adduct. Science 294 (2001) 1346-1349
23. Li J., Zhu M., Manning-Bog A.B., Monte D.A.D., and Fink A.L. Dopamine and l-DOPA disaggregate amyloid fibrils: implications for Parkinson's and Alzheimer's disease. FASEB J. 18 (2004) 962-964
24. Matsuzaki K., Noguch T., Wakabayashi M., Ikeda K., Okada T., Ohashi Y., Hoshino M., and Naiki H. Inhibitors of amyloid β-protein aggregation mediated by GM1-containing raft-like membranes. Biochim. Biophys. Acta 1768 (2007) 122-130
25. Kakio A., Yano Y., Takai D., Kuroda Y., Matsumoto O., Kozutsumi Y., and Matsuzaki K. Interaction between amyloid β-protein aggregates and membranes. J. Peptide Sci. 10 (2004) 612-621
26. Andersen C.B., Yagi H., Manno M., Martorana V., Ban T., Christiansen G., Otzen D.E., Goto Y., and Rischel C. Branching in amyloid fibril growth. Biophys. J. 96 (2009) 1529-1536
27. Yagi H., Ban T., Morigaki K., Naiki H., and Goto Y. Visualization and classification of amyloid β supuramolecular assemblies. Biochemistry 46 (2007) 15009-15017
28. Shimanouchi T., Ishii H., Yoshimoto N., Umakoshi H., and Kuboi R. Calcein permeation across phosphatidylcholine bilayer membrane: effects of membrane fluidity, liposome size, and immobilization. Coll. Surf. B 73 (2009) 156-160
29. Kuboi R., Shimanouchi T., Yoshimoto M., and Umakoshi H. Detection of protein conformation under stress condition using liposomes as sensor materials. Sens. Mater. 16 5 (2004) 241-254
30. Soto C., Sigurdsson E.M., Morelli L., Kumar A., Castano E.M., and Frangione B. β-Sheet breaker pepides inhibit fibrillogenesis in a rat brain model of amyloidosis: implication for Alzheimer's therapy. Nat. Med. 4 (1998) 822-826
31. Nuria B.C., Mercedes C., and Josep C. Conversion of non-fi{ligature}brillar β-sheet oligomers into amyloid fi{ligature}brils in Alzheimer's disease amyloid peptide aggregation. Biochem. Biophys. Res. Com. 361 (2007) 916-921
32. Naiki H., and Nakakuki K. First-order kinetic model of Alzheimer's beta-amyloid fibril extension in vitro. Lab. Invest. 74 (1996) 374-383
33. Petkova A.T., Ishii Y., Balbach J.J., Antzukin O.N., Leapman R.D., Delaglio F., and Tycko R. A structural model for Alzheimer's β-amyloid fibrils based on experimental constraints from solid state NMR. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 16742-16747